ArticleCancers2025
Prognostic Value of PLR, SIRI, PIV, SII, and NLR in Non-Muscle Invasive Bladder Cancer: Can Inflammatory Factors Influence Pathogenesis and Outcomes?
Abstract read
In one paragraph
Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 2 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 2 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Prognostic value of systemic inflammatory response index in patients with bladder cancer: a systematic review and meta-analysis.Frontiers in oncology · 2026Pooled it
- Prognostic value of the systemic immune-inflammation index in bladder cancer: an update evidence-based analysis.Frontiers in oncology · 2025Pooled it
- Real-World Outcomes and Prognostic Factors in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Treated with Sorafenib: A Multicenter Study.Journal of clinical medicine · 2026Article
- Oncologic outcomes of transurethral resection versus laser excision for non-muscle invasive bladder cancer: a SEER retrospective cohort study.Translational andrology and urology · 2026Article
- Investigation of angiogenesis and epithelial-mesenchymal transition markers (CD31, VEGF, and E-Cadherin) in prostatic cancer patients: a multi-omics study.World journal of surgical oncology · 2026Article
- A multidimensional nomogram integrating immune, inflammatory, and coagulation markers for personalized prognosis in bladder cancer.The Journal of international medical research · 2026Article
- Potential Diagnostic and Prognostic Value of Neutrophil Counts, Neutrophil-Lymphocyte Ratio, Pan-Immunoinflammatory Score, Systemic Immunoinflammatory Index, and Systemic Inflammatory Response Index in Brain Tumors.Diagnostics (Basel, Switzerland) · 2026Article
- Review
- CALLY index provides improved prognostic stratification compared with other inflammation-based scores in glioblastoma treated with the stupp protocol.BMC cancer · 2026Article
- Fibroblast-associated CTHRC1 as a key indicator of recurrence risk in prostate cancer.World journal of surgical oncology · 2026Article
- Combined Model of Inflammatory-Nutritional Indicators and Tumor Markers for Predicting Prognosis in Patients with Distal Cholangiocarcinoma: A Retrospective Cohort Study.Diseases (Basel, Switzerland) · 2026Article
- Survival Prediction in Patients With Bladder Cancer Undergoing Radical Cystectomy Using a Machine Learning Algorithm: Retrospective Single-Center Study.JMIR perioperative medicine · 2026Article
- Comparative value of postoperative inflammatory indices in predicting recurrence in T3 stage renal cell carcinoma: superiority of the Cally index.BMC urology · 2026Article
- Review
- Prognostic Value of the Lung Immune Prognostic Index (LIPI) in Patients with Renal Cell Carcinoma: A Retrospective Cohort Study.Journal of clinical medicine · 2026Article
- Application of serum miRNA panel in bladder cancer detection.Translational andrology and urology · 2026Article
- CD36 rs1761667 Polymorphism and Its Impact on Molecular Signatures in Bladder Cancer.Diseases (Basel, Switzerland) · 2026Article
- Trop-2 expression is associated with poor survival in pleural mesothelioma.Frontiers in oncology · 2026Article
- Article
- Investigation of the Correlation Between Selected miRNAs, Proinflammatory Cytokines, and Serum Trace Elements in Bladder Cancer Development and Progression.Current issues in molecular biology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Francesco Pio BizzarriDepartment of Urology, Fondazione Policlinico Universitario Agostino Gemelli, 00168 Rome, Italy.ORCID 0000-0003-2119-9023
Marco CampetellaDepartment of Urology, Ospedale Isola Tiberina-Gemelli Isola, 00186 Rome, Italy.ORCID 0000-0002-7412-1214
Pierluigi RussoDepartment of Urology, Fondazione Policlinico Universitario Agostino Gemelli, 00168 Rome, Italy.
Giuseppe PalermoDepartment of Urology, Fondazione Policlinico Universitario Agostino Gemelli, 00168 Rome, Italy.ORCID 0000-0002-3861-3545
Seyed Koosha MoosaviDepartment of Urology, Fondazione Policlinico Universitario Agostino Gemelli, 00168 Rome, Italy.
Francesco RossiDepartment of Urology, Fondazione Policlinico Universitario Agostino Gemelli, 00168 Rome, Italy.
Lorenzo D'AmicoDepartment of Urology, Ospedale Isola Tiberina-Gemelli Isola, 00186 Rome, Italy.
Antonio CretìDepartment of Urology, Fondazione Policlinico Universitario Agostino Gemelli, 00168 Rome, Italy.
Filippo GaviDepartment of Urology, Fondazione Policlinico Universitario Agostino Gemelli, 00168 Rome, Italy.ORCID 0000-0001-9994-4316
Enrico PanioDepartment of Urology, Fondazione Policlinico Universitario Agostino Gemelli, 00168 Rome, Italy.
Simona PresuttiDepartment of Urology, Fondazione Policlinico Universitario Agostino Gemelli, 00168 Rome, Italy.
Fabrizio BellaviaDepartment of Urology, Fondazione Policlinico Universitario Agostino Gemelli, 00168 Rome, Italy.
Mauro RagoneseDepartment of Urology, Fondazione Policlinico Universitario Agostino Gemelli, 00168 Rome, Italy.ORCID 0000-0002-1919-8729
Chiara CiccareseDepartment of Oncology, Fondazione Policlinico Universitario Agostino Gemelli, 00168 Rome, Italy.
Roberto IacovelliDepartment of Oncology, Fondazione Policlinico Universitario Agostino Gemelli, 00168 Rome, Italy.ORCID 0000-0002-1750-2117
Maria Chiara SighinolfiDepartment of Urology, Fondazione Policlinico Universitario Agostino Gemelli, 00168 Rome, Italy.
Marco RacioppiDepartment of Urology, Fondazione Policlinico Universitario Agostino Gemelli, 00168 Rome, Italy.ORCID 0000-0001-9129-8479
Emilio SaccoDepartment of Urology, Ospedale Isola Tiberina-Gemelli Isola, 00186 Rome, Italy.
Bernardo RoccoDepartment of Urology, Fondazione Policlinico Universitario Agostino Gemelli, 00168 Rome, Italy.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
bladder cancerinflammatory factorsnon-muscle invasive bladder cancer
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.